Items where authors include "Hull, M.A."

Export as [feed] Atom [feed] RSS
Jump to: Article
Number of items: 14.

Article

Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2024) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer, 154 (5). pp. 873-885. ISSN 0020-7136

Aldoori, J., Zulyniak, M.A., Toogood, G.J. et al. (1 more author) (2024) Fish oil supplement use modifies the relationship between dietary oily fish intake and plasma omega-3 polyunsaturated fatty acid levels: An analysis of the UK Biobank. British Journal of Nutrition. ISSN 0007-1145

Hull, M.A. orcid.org/0000-0001-7414-1576, Ow, P.L., Ruddock, S. et al. (16 more authors) (2023) Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (EPA) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: EPA for Metastasis Trial 2 (EMT2) study protocol. BMJ Open, 13 (11). e077427. ISSN 2044-6055

Madurasinghe, V.W., Knapp, P., Eldridge, S. et al. (16 more authors) (2023) Can we achieve better trial recruitment by presenting patient information through multimedia? Meta-analysis of ‘studies within a trial’ (SWATs). BMC Medicine, 21 (1). 425. ISSN 1741-7015

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Davies, J.R. orcid.org/0009-0002-4272-2477, Mell, T. orcid.org/0009-0001-6744-1340, Fuller, H. orcid.org/0000-0001-8381-519X et al. (10 more authors) (2023) Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial. Cancer Prevention Research, 16 (11). pp. 621-630. ISSN 1940-6207

Sun, G., Fuller, H., Fenton, H. et al. (7 more authors) (2023) The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E2 synthesis and platelet activation in participants of the seAFOod polyp prevention trial. International Journal of Cancer. ISSN 0020-7136

Downing, A. orcid.org/0000-0002-0335-7801, Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology and Therapeutics, 58 (6). pp. 562-572. ISSN 0269-2813

Downing, A., Fenton, H., Nickerson, C. et al. (6 more authors) (2023) Colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: evidence of rebound elevated colorectal polyp risk after short-term aspirin use. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813

Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278

Fuller, H., Race, A.D., Fenton, H. et al. (7 more authors) (2023) Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial. Prostaglandins, Leukotrienes and Essential Fatty Acids, 192. 102570. ISSN 0952-3278

Volpato, M. orcid.org/0000-0002-7851-4533, Ingram, N. orcid.org/0000-0001-5274-8502, Perry, S.L. et al. (8 more authors) (2020) Correction to: Cyclooxygenase activity mediates colorectal cancer cell resistance to the omega‑3 polyunsaturated fatty acid eicosapentaenoic acid. Cancer Chemotherapy and Pharmacology, 87 (6). pp. 879-880. ISSN 0344-5704

Hull, M.A., Sprange, K., Hepburn, T. et al. (10 more authors) (2018) Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial. Lancet, 392 (10164). pp. 2583-2594. ISSN 0140-6736

Sonwalkar, S.A., James, R.M., Ahmad, T. et al. (5 more authors) (2003) Fulminant Crohn's colitis after allogeneic stem cell transplantation. Gut, 52 (10). pp. 1518-1521. ISSN 0017-5749

This list was generated on Sat May 4 22:43:36 2024 BST.